University of New Mexico Cancer Center Support Grant

新墨西哥大学癌症中心支持补助金

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The Cancer Control (CaC) Research Program is a newly restructured transdisciplinary program that serves as the hub for cancer control and population science research within the University of New Mexico Cancer Center (UNMCC) and the State of New Mexico (NM), our catchment area. The Program's overall goal is to reduce cancer incidence, morbidity, and mortality, particularly in the unique multiethnic and underserved populations of NM. Disparities research is a cross-cutting theme that fosters scientific focus and synergy across the research areas. Through vigorous strategic program planning and evaluation, recruitment of 9 new investigators to enhance expertise in molecular epidemiology and behavioral/community intervention, and guidance of the UNMCC External Advisory Committee, the CaC Program is now focused on three areas of cancer research: 1) Risk Prediction and Risk Reduction; 2) Screening; and 3) Post-Diagnosis Outcomes and Survivorship. Unique scientific strengths include research addressing disparities (geographic, race/ethnic, socioeconomic, medically underserved), particularly in etiologic, outcome, and intervention studies in Hispanics. By drawing on established and new partnerships, the Program is also building research that addresses American Indian cancer disparities and priorities identified by NM Tribes, Pueblos, and Indian Nations. Major scientific accomplishments in Risk Prediction and Risk Reduction include the identification of social, lifestyle, and genetic factors associated with lung cancer risk; gene-environment interactions in melanoma risk; and development and dissemination of a novel telehealth strategy for the prevention of hepatocellular cancer. In Screening, members have developed a statewide surveillance program of screening and diagnosis for cervical pre-cancer and cancer that informs real- world cervical cancer prevention through human papilloma virus (HPV) vaccination, screening practice and outcomes. Members have also identified barriers to use of early detection tests in colorectal cancer and have developed strategies to overcome these barriers to improve screening in underserved populations. In Post- Diagnosis Outcomes and Survivorship, members have identified factors that contribute to disparities in post- treatment outcomes and survivorship in endometrial and breast cancer and are developing interventions. Led by Linda Cook, Ph.D. and Anita Kinney, Ph.D., RN, the CaC Program is comprised of 28 members (19 full and 9 associate) from 7 UNM schools and departments, the Lovelace Respiratory Institute, and the Indian Health Service Unit of the Centers for Disease Control whose work is supported by $19,276,863 million in annual direct cost funding, of which $15,429,911 million is peer-reviewed and $3,137,820 million is from NCI as of 9/1/2014. The discoveries made in this Program have resulted 294 publications, of which 19% are intra-programmatic collaborations and 16% are inter-programmatic collaborations; with a total UNMCC and external collaborative publication level of 30% and 80%, respectively.
 描述(由申请人提供):癌症控制 (CaC) 研究计划是一个新重组的跨学科计划,作为新墨西哥大学癌症中心 (UNMCC) 和新墨西哥州癌症控制和人口科学研究的中心(NM),我们的服务区域,该计划的总体目标是降低癌症发病率、发病率和死亡率,特别是在新墨西哥州独特的多种族和服务不足的人群中。通过积极的战略计划规划和评估、招募 9 名新研究人员以增强分子流行病学和行为/社区干预方面的专业知识,以及 UNMCC 外部咨询委员会的指导,CaC 计划现在的重点是促进跨研究领域的科学重点和协同作用。癌症研究的三个领域:1) 风险预测和风险降低;2) 筛查;3) 诊断后结果和生存率,包括解决差异的研究。 (地理、种族/族裔、社会经济、医疗服务不足),特别是在西班牙裔的病因、结果和干预研究方面,该计划还利用已建立的和新的伙伴关系开展研究,解决美洲印第安人癌症差异和 NM 确定的优先事项。部落、普韦布洛和印第安民族在风险预测和降低风险方面的主要科学成就包括识别与肺癌风险以及黑色素瘤的发展和传播相关的社会、生活方式和遗传因素;预防肝细胞癌的新型远程医疗策略 In Screening 成员制定了一项省级宫颈癌前病变和癌症筛查和诊断监测计划,通过人乳头状瘤病毒 (HPV) 疫苗接种、筛查为现实世界的宫颈癌预防提供信息。成员们还确定了结直肠癌早期检测检测的障碍,并制定了克服这些障碍的策略,以改善服务不足人群的筛查。在诊断后结果和生存率中,成员们确定了影响结直肠癌的因素。 CaC 项目由 Linda Cook 博士和 Anita Kinney 博士、注册护士领导,由 28 名成员(19 名正式成员和 19 名成员)组成。 9 名助理)来自新墨西哥州 7 个学校和部门、洛夫莱斯呼吸研究所和疾病控制中心印第安人卫生服务部门,其工作得到了 192,768.63 亿美元的年度直接成本支持截至 2014 年 9 月 1 日,该计划中的发现已产生 294 篇出版物,其中 19% 为项目内合作,16% 为项目间合作,其中 15,429,911 百万美元经过同行评审,3,137,820 百万美元来自 NCI。项目合作;UNMCC 和外部合作出版水平分别为 30% 和 80%。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alan E Tomkinson其他文献

Alan E Tomkinson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alan E Tomkinson', 18)}}的其他基金

Targeting DNA Ligase I in Ovarian Cancer
靶向 DNA 连接酶 I 治疗卵巢癌
  • 批准号:
    10737536
  • 财政年份:
    2023
  • 资助金额:
    $ 224.6万
  • 项目类别:
The 5th US-EU Conference on Endogenous DNA Damage
第五届美国-欧盟内源性 DNA 损伤会议
  • 批准号:
    8785881
  • 财政年份:
    2014
  • 资助金额:
    $ 224.6万
  • 项目类别:
Cellular Functions of Eukaryotic DNA Ligases
真核 DNA 连接酶的细胞功能
  • 批准号:
    7989620
  • 财政年份:
    2009
  • 资助金额:
    $ 224.6万
  • 项目类别:
Program Leaders of Research Programs
研究项目负责人
  • 批准号:
    7696567
  • 财政年份:
    2008
  • 资助金额:
    $ 224.6万
  • 项目类别:
Leadership, Planning and Evaluation
领导、规划和评估
  • 批准号:
    10491134
  • 财政年份:
    2005
  • 资助金额:
    $ 224.6万
  • 项目类别:
Strengthen the Research, Training, and Outreach Capacity of the Geographical Management of Cancer Health Disparities Program (GMaP)
加强癌症健康差异地理管理计划 (GMaP) 的研究、培训和推广能力
  • 批准号:
    10372808
  • 财政年份:
    2005
  • 资助金额:
    $ 224.6万
  • 项目类别:
We Ask Because We Care: Enhancing Sexual Orientation and Gender Identity Data Collection in New Mexico Cancer Centers (Ask SOGI)
我们因关心而提问:加强新墨西哥州癌症中心的性取向和性别认同数据收集(询问 SOGI)
  • 批准号:
    10640767
  • 财政年份:
    2005
  • 资助金额:
    $ 224.6万
  • 项目类别:
University of New Mexico Cancer Center Support Grant
新墨西哥大学癌症中心支持补助金
  • 批准号:
    10271925
  • 财政年份:
    2005
  • 资助金额:
    $ 224.6万
  • 项目类别:
Administrative Supplement to Strengthen NCI-Supported Community Outreach Capacity Through Community Health Educators of the National Outreach Network (NON CHE)
通过国家外展网络 (NON CHE) 的社区健康教育者加强 NCI 支持的社区外展能力的行政补充
  • 批准号:
    10372735
  • 财政年份:
    2005
  • 资助金额:
    $ 224.6万
  • 项目类别:
University of New Mexico Cancer Center Support Grant
新墨西哥大学癌症中心支持补助金
  • 批准号:
    10514685
  • 财政年份:
    2005
  • 资助金额:
    $ 224.6万
  • 项目类别:

相似海外基金

Planning and Evaluation Core
规划与评估核心
  • 批准号:
    10762147
  • 财政年份:
    2023
  • 资助金额:
    $ 224.6万
  • 项目类别:
Planning and Evaluation Core
规划与评估核心
  • 批准号:
    10762276
  • 财政年份:
    2023
  • 资助金额:
    $ 224.6万
  • 项目类别:
Cancer-related cognitive impairment: Real-time evaluation and assessment of long-term impact of treatment on young adult survivors (CRCI REALITY)
癌症相关认知障碍:实时评估和评估治疗对年轻成年幸存者的长期影响(CRCI REALITY)
  • 批准号:
    10427965
  • 财政年份:
    2022
  • 资助金额:
    $ 224.6万
  • 项目类别:
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities
青少年处方阿片类药物使用障碍导致的神经认知障碍:纵向影响、神经机制和合并症
  • 批准号:
    10481236
  • 财政年份:
    2022
  • 资助金额:
    $ 224.6万
  • 项目类别:
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
  • 批准号:
    10709604
  • 财政年份:
    2022
  • 资助金额:
    $ 224.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了